{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:58:09Z","timestamp":1782917889134,"version":"3.54.5"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan","award":["#18K14594"],"award-info":[{"award-number":["#18K14594"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Metab Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The upregulation of cyclooxygenase-2 (COX-2) and the subsequent production of prostaglandin E\n                    <jats:sub>2<\/jats:sub>\n                    (PGE\n                    <jats:sub>2<\/jats:sub>\n                    ) in synovial tissue are hallmarks of autoimmune arthritis, including rheumatoid arthritis (RA). While glucosamine (GlcN) derivatives modulate RA symptoms, their specific anti-inflammatory mechanisms in synovial fibroblasts (SFBs) are poorly understood. In this study, we evaluated the anti-inflammatory efficacy of various GlcN derivatives: glucosamine hydrochloride (GlcN-HCl), glucosamine sulfate (GlcN-S), glucosaminate (GlcNA), and N-acetylglucosamine (GlcNAc). GlcN-HCl and GlcN-S inhibited IL-1\u03b2-induced PGE\n                    <jats:sub>2<\/jats:sub>\n                    release and the expression of COX-2 at both protein and mRNA levels, whereas GlcNA and GlcNAc exhibited no such inhibitory activity. Structure-activity relationship analysis using GlcN-HCl epimers revealed that whereas the C-4 epimer, galactosamine hydrochloride (GalN-HCl), retained potent anti-inflammatory effects, the C-2 epimer, mannosamine hydrochloride (ManN-HCl), showed significantly diminished bioactivity, highlighting the critical role of the C-2 stereochemical configuration in modulating inflammatory responses. Mechanistically, we demonstrated that GlcN-HCl-mediated COX-2 suppression occurs via epigenetic silencing rather than mRNA destabilization. GlcN-HCl treatment significantly reduced the enrichment of active chromatin marks, H3K27ac and H3K4me3, at the COX-2 promoter, whereas mRNA stability remained unaffected. Given that metabolic dysregulation is intrinsically linked to inflammatory pathogenesis, we characterized the metabolic profile of GlcN-HCl-treated SFBs. We found that GlcN-HCl triggers metabolic reprogramming of the polyol pathway by modulating the expression of\n                    <jats:italic>AKR1B1<\/jats:italic>\n                    and sorbitol dehydrogenase (\n                    <jats:italic>SORD<\/jats:italic>\n                    ), resulting in elevated intracellular sorbitol levels. Pharmacological inhibition of AKR1B1 effectively abrogated the anti-inflammatory effects of GlcN-HCl, indicating that polyol pathway activation is essential for its efficacy. We confirmed the evolutionary conservation of these findings in human SFBs, demonstrating the translational relevance of the GlcN-HCl-mediated metabolic and epigenetic axis. Our findings demonstrate that GlcN-HCl induces metabolic reprogramming of the polyol pathway in synovial fibroblasts, facilitating the epigenetic silencing of inflammatory mediators. This metabolic-epigenetic axis suggests a mechanistic rationale for pharmacological metabolic intervention in RA, shifting the therapeutic paradigm toward targeted reprogramming of synovial fibroblast metabolism.\n                  <\/jats:p>","DOI":"10.1038\/s44324-026-00118-0","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:41:18Z","timestamp":1782916878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic reprogramming in polyol pathway contributes to anti-inflammatory effect of glucosamine salts on synovial fibroblasts"],"prefix":"10.1038","volume":"4","author":[{"given":"Junichi","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanako","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Namba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuto","family":"Naruke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Nunomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Suwabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadayoshi","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Tohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Uechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sugiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"118_CR1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S1359-6101(02)00021-7","volume":"13","author":"Y Iwakura","year":"2002","unstructured":"Iwakura, Y. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine Growth Factor Rev. 13, 341\u2013355 (2002).","journal-title":"Cytokine Growth Factor Rev."},{"key":"118_CR2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2174\/1574887113666180314102651","volume":"13","author":"P Ruscitti","year":"2018","unstructured":"Ruscitti, P. et al. The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes. Rev. Recent Clin. Trials 13, 210\u2013214 (2018).","journal-title":"Rev. Recent Clin. Trials"},{"key":"118_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","volume":"6","author":"C Gabay","year":"2010","unstructured":"Gabay, C., Lamacchia, C. & Palmer, G. IL-1 pathways in inflammation and human diseases. Nat. Rev. Rheumatol. 6, 232\u2013241 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"118_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1517\/13543784.9.1.113","volume":"9","author":"C Gabay","year":"2000","unstructured":"Gabay, C. IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis. Expert. Opin. Investig. Drugs 9, 113\u2013127 (2000).","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"118_CR5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.gene.2013.05.069","volume":"527","author":"AS Lee","year":"2013","unstructured":"Lee, A. S. et al. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene 527, 440\u2013447 (2013).","journal-title":"Gene"},{"key":"118_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/ar112","volume":"2","author":"C Ritchlin","year":"2000","unstructured":"Ritchlin, C. Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis. Arthritis Res. 2, 356\u2013360 (2000).","journal-title":"Arthritis Res."},{"key":"118_CR7","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1096\/fj.13-234542","volume":"27","author":"P Wang","year":"2013","unstructured":"Wang, P. et al. Fluid shear stress-induced osteoarthritis: roles of cyclooxygenase-2 and its metabolic products in inducing the expression of proinflammatory cytokines and matrix metalloproteinases. FASEB J. 27, 4664\u20134677 (2013).","journal-title":"FASEB J."},{"key":"118_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/srep39914","volume":"7","author":"T Kitanaka","year":"2017","unstructured":"Kitanaka, T. et al. JNK activation is essential for activation of MEK\/ERK signaling in IL-1\u03b2-induced COX-2 expression in synovial fibroblasts. Sci. Rep. 7, 39914 (2017).","journal-title":"Sci. Rep."},{"key":"118_CR9","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2006.068403","volume":"67","author":"GS Metsios","year":"2008","unstructured":"Metsios, G. S. et al. Cigarette smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis. Ann. Rheum. Dis. 67, 70\u201373 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"118_CR10","doi-asserted-by":"publisher","first-page":"e0163087","DOI":"10.1371\/journal.pone.0163087","volume":"11","author":"BV Cuppen","year":"2016","unstructured":"Cuppen, B. V. et al. & all Society for Rheumatology Research Utrecht investigators. Exploring the inflammatory metabolomic profile to predict response to TNF-\u03b1 inhibitors in rheumatoid arthritis. PLOS ONE 11, e0163087 (2016).","journal-title":"PLOS ONE"},{"key":"118_CR11","doi-asserted-by":"crossref","unstructured":"Sweeney, S. R. et al. Metabolomic profiling predicts outcome of rituximab therapy in rheumatoid arthritis. RMD Open. 2, e000289 (2016).","DOI":"10.1136\/rmdopen-2016-000289"},{"key":"118_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1214-5","volume":"17","author":"Z Tatar","year":"2016","unstructured":"Tatar, Z. et al. Variations in the metabolome in response to disease activity of rheumatoid arthritis. BMC Musculoskelet. Disord. 17, 353 (2016).","journal-title":"BMC Musculoskelet. Disord."},{"key":"118_CR13","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/art.38021","volume":"65","author":"SP Young","year":"2013","unstructured":"Young, S. P. et al. The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum. 65, 2015\u20132023 (2013).","journal-title":"Arthritis Rheum."},{"key":"118_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0681-8","volume":"14","author":"A Alonso","year":"2016","unstructured":"Alonso, A. et al. & IMID Consortium. Urine metabolome profiling of immune-mediated inflammatory diseases. BMC Med. 14, 133 (2016).","journal-title":"BMC Med."},{"key":"118_CR15","first-page":"240","volume":"30","author":"T H\u00fcgle","year":"2012","unstructured":"H\u00fcgle, T. et al. Synovial fluid metabolomics in different forms of arthritis assessed by nuclear magnetic resonance spectroscopy. Clin. Exp. Rheumatol. 30, 240\u2013245 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"118_CR16","doi-asserted-by":"publisher","first-page":"e97501","DOI":"10.1371\/journal.pone.0097501","volume":"9","author":"S Kim","year":"2014","unstructured":"Kim, S. et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLOS ONE 9, e97501 (2014).","journal-title":"PLOS ONE"},{"key":"118_CR17","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/art.40504","volume":"70","author":"J Falconer","year":"2018","unstructured":"Falconer, J. et al. Review: synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis Rheumatol. 70, 984\u2013999 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"118_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00011-004-1333-6","volume":"54","author":"J Hua","year":"2005","unstructured":"Hua, J., Suguro, S., Hirano, S., Sakamoto, K. & Nagaoka, I. Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm. Res. 54, 127\u2013132 (2005).","journal-title":"Inflamm. Res."},{"key":"118_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.biopha.2018.05.136","volume":"105","author":"W Dai","year":"2018","unstructured":"Dai, W., Qi, C. & Wang, S. Synergistic effect of glucosamine and vitamin E against experimental rheumatoid arthritis in neonatal rats. Biomed. Pharmacother. 105, 835\u2013840 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"118_CR20","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1039\/C9FO00981G","volume":"10","author":"S Kashiuchi","year":"2019","unstructured":"Kashiuchi, S. et al. Effects of administration of glucosamine and chicken cartilage hydrolysate on rheumatoid arthritis in SKG mice. Food Funct. 10, 5008\u20135017 (2019).","journal-title":"Food Funct."},{"key":"118_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-020-00987-8","volume":"10","author":"JM Zhao","year":"2020","unstructured":"Zhao, J. M., Chen, X., Cheng, K., Shi, Q. & Peng, K. Anserine and glucosamine supplementation attenuates the levels of inflammatory markers in rats with rheumatoid arthritis. AMB Express 10, 57 (2020).","journal-title":"AMB Express"},{"key":"118_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00296-006-0197-1","volume":"27","author":"H Nakamura","year":"2007","unstructured":"Nakamura, H. et al. Effects of glucosamine administration on patients with rheumatoid arthritis. Rheumatol. Int. 27, 213\u2013218 (2007).","journal-title":"Rheumatol. Int."},{"key":"118_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.579266","volume":"11","author":"R Nakano","year":"2020","unstructured":"Nakano, R. et al. Non-transcriptional and translational function of canonical NF-\u03baB signaling in activating ERK1\/2 in IL-1\u03b2-induced COX-2 expression in synovial fibroblasts. Front. Immunol. 11, 579266 (2020).","journal-title":"Front. Immunol."},{"key":"118_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/cei\/uxab021","volume":"208","author":"MM Hanlon","year":"2022","unstructured":"Hanlon, M. M., Canavan, M., Barker, B. E. & Fearon, U. Metabolites as drivers and targets in rheumatoid arthritis. Clin. Exp. Immunol. 208, 167\u2013180 (2022).","journal-title":"Clin. Exp. Immunol."},{"key":"118_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.1258366","volume":"348","author":"J Gerdts","year":"2015","unstructured":"Gerdts, J., Brace, E. J., Sasaki, Y., DiAntonio, A. & Milbrandt, J. SARM1 activation triggers axon degeneration locally via NAD\u207a destruction. Science 348, 453\u2013457 (2015).","journal-title":"Science"},{"key":"118_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0049-3848(97)00100-X","volume":"86","author":"JP De la Cruz","year":"1997","unstructured":"De la Cruz, J. P., Maximo, M. A., Blanco, E., Moreno, A. & S\u00e1nchez de la Cuesta, F. Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitro. Thromb. Res. 86, 515\u2013524 (1997).","journal-title":"Thromb. Res."},{"key":"118_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1017\/S0967199413000567","volume":"23","author":"T Lin","year":"2015","unstructured":"Lin, T., Zhang, J. Y., Diao, Y. F., Kang, J. W. & Jin, D. I. Effects of sorbitol on porcine oocyte maturation and embryo development in vitro. Zygote 23, 297\u2013306 (2015).","journal-title":"Zygote"},{"key":"118_CR28","doi-asserted-by":"publisher","first-page":"G547","DOI":"10.1152\/ajpgi.00174.2011","volume":"301","author":"K Ban","year":"2011","unstructured":"Ban, K., Sprunt, J. M., Martin, S., Yang, P. & Kozar, R. A. Glutamine activates peroxisome proliferator-activated receptor-\u03b3 in intestinal epithelial cells via 15-S-HETE and 13-OXO-ODE: a novel mechanism. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G547\u2013G554 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"118_CR29","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1677\/joe.1.06892","volume":"190","author":"M Corless","year":"2006","unstructured":"Corless, M., Kiely, A., McClenaghan, N. H., Flatt, P. R. & Newsholme, P. Glutamine regulates expression of key transcription factor, signal transduction, metabolic gene, and protein expression in a clonal pancreatic beta-cell line. J. Endocrinol. 190, 719\u2013727 (2006).","journal-title":"J. Endocrinol."},{"key":"118_CR30","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41584-022-00771-x","volume":"18","author":"U Fearon","year":"2022","unstructured":"Fearon, U., Hanlon, M. M., Floudas, A. & Veale, D. J. Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications. Nat. Rev. Rheumatol. 18, 398\u2013414 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"118_CR31","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s42003-020-01260-1","volume":"3","author":"J Li","year":"2020","unstructured":"Li, J., Chen, J., An, L., Yuan, X. & Yao, L. Polyol and sugar osmolytes can shorten protein hydrogen bonds to modulate function. Commun. Biol. 3, 528 (2020).","journal-title":"Commun. Biol."},{"key":"118_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813\u2013820 (2001).","journal-title":"Nature"},{"key":"118_CR33","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/nchembio.194","volume":"5","author":"TB Dansen","year":"2009","unstructured":"Dansen, T. B. et al. Redox-sensitive cysteines bridge p300\/CBP-mediated acetylation and FoxO4 activity. Nat. Chem. Biol. 5, 664\u2013672 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"118_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1465849","volume":"15","author":"H Sun","year":"2024","unstructured":"Sun, H. et al. The relationship between SIRT1 and inflammation: a systematic review and meta-analysis. Front. Immunol. 15, 1465849 (2024).","journal-title":"Front. Immunol."},{"key":"118_CR35","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s00011-007-7020-7","volume":"56","author":"J Hua","year":"2007","unstructured":"Hua, J. et al. Evaluation of the suppressive actions of glucosamine on the interleukin-1\u03b2-mediated activation of synoviocytes. Inflamm. Res. 56, 432\u2013438 (2007).","journal-title":"Inflamm. Res."},{"key":"118_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fphar.2012.00148","volume":"3","author":"E Pastel","year":"2012","unstructured":"Pastel, E., Pointud, J. C., Volat, F., Martinez, A. & Lefran\u00e7ois-Martinez, A. M. Aldo-Keto Reductases 1B in endocrinology and metabolism. Front. Pharmacol. 3, 148 (2012).","journal-title":"Front. Pharmacol."},{"key":"118_CR37","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3892\/or_00000755","volume":"23","author":"Z Vaarala","year":"2010","unstructured":"Vaarala, Z., H\u00e4m\u00e4l\u00e4inen, J. & Loikkanen, I. Sorbitol dehydrogenase expression is regulated by androgens in the human prostate. Oncol. Rep. 23, 1233\u20131239 (2010).","journal-title":"Oncol. Rep."},{"key":"118_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.vetimm.2015.10.003","volume":"168","author":"H Tsuchiya","year":"2015","unstructured":"Tsuchiya, H. et al. Activation of MEK\/ERK pathways through NF-\u03baB activation is involved in interleukin-1\u03b2-induced cyclooxygenease-2 expression in canine dermal fibroblasts. Vet. Immunol. Immunopathol. 168, 223\u2013232 (2015).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"118_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26473-7","volume":"8","author":"R Nakano","year":"2018","unstructured":"Nakano, R., Kitanaka, T., Namba, S., Kitanaka, N. & Sugiya, H. Protein kinase C\u03b5 regulates nuclear translocation of extracellular signal-regulated kinase, which contributes to bradykinin-induced cyclooxygenase-2 expression. Sci. Rep. 8, 8535 (2018).","journal-title":"Sci. Rep."},{"key":"118_CR40","doi-asserted-by":"publisher","first-page":"e0229892","DOI":"10.1371\/journal.pone.0229892","volume":"15","author":"R Nakano","year":"2020","unstructured":"Nakano, R. et al. All-trans retinoic acid induces reprogramming of canine dedifferentiated cells into neuron-like cells. PLOS ONE 15, e0229892 (2020).","journal-title":"PLOS ONE"},{"key":"118_CR41","doi-asserted-by":"publisher","first-page":"e0243859","DOI":"10.1371\/journal.pone.0243859","volume":"16","author":"Y Suwabe","year":"2021","unstructured":"Suwabe, Y. et al. Involvement of GLUT1 and GLUT3 in the growth of canine melanoma cells. PLOS ONE 16, e0243859 (2021).","journal-title":"PLOS ONE"},{"key":"118_CR42","doi-asserted-by":"publisher","first-page":"e0259489","DOI":"10.1371\/journal.pone.0259489","volume":"16","author":"A Naruke","year":"2021","unstructured":"Naruke, A. et al. Tpl2 contributes to IL-1\u03b2-induced IL-8 expression via ERK1\/2 activation in canine dermal fibroblasts. PLOS ONE 16, e0259489 (2021).","journal-title":"PLOS ONE"},{"key":"118_CR43","doi-asserted-by":"publisher","first-page":"e0278220","DOI":"10.1371\/journal.pone.0278220","volume":"17","author":"J Nunomura","year":"2022","unstructured":"Nunomura, J. et al. Interleukin-1\u03b2 triggers matrix metalloprotease-3 expression through p65\/RelA activation in melanoma cells. PLOS ONE 17, e0278220 (2022).","journal-title":"PLOS ONE"},{"key":"118_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1292\/jvms.14-0284","volume":"77","author":"R Nakano","year":"2015","unstructured":"Nakano, R. et al. Differentiation of canine bone marrow stromal cells into voltage- and glutamate-responsive neuron-like cells by basic fibroblast growth factor. J. Vet. Med. Sci. 77, 27\u201335 (2015).","journal-title":"J. Vet. Med. Sci."},{"key":"118_CR45","doi-asserted-by":"publisher","first-page":"e0141581","DOI":"10.1371\/journal.pone.0141581","volume":"10","author":"R Nakano","year":"2015","unstructured":"Nakano, R. et al. Fibroblast growth factor Receptor-2 contributes to the basic fibroblast growth factor-induced neuronal differentiation in canine bone marrow stromal cells via phosphoinositide 3-kinase\/Akt signaling pathway. PLOS ONE 10, e0141581 (2015).","journal-title":"PLOS ONE"},{"key":"118_CR46","doi-asserted-by":"publisher","first-page":"e0166707","DOI":"10.1371\/journal.pone.0166707","volume":"11","author":"T Konno","year":"2016","unstructured":"Konno, T. et al. Expression and function of interleukin-1\u03b2-induced neutrophil gelatinase-associated lipocalin in renal tubular cells. PLOS ONE 11, e0166707 (2016).","journal-title":"PLOS ONE"},{"key":"118_CR47","doi-asserted-by":"publisher","first-page":"e0208955","DOI":"10.1371\/journal.pone.0208955","volume":"13","author":"N Kitanaka","year":"2018","unstructured":"Kitanaka, N. et al. NF-\u03baB p65 and p105 implicate in interleukin 1\u03b2-mediated COX-2 expression in melanoma cells. PLOS ONE 13, e0208955 (2018).","journal-title":"PLOS ONE"},{"key":"118_CR48","doi-asserted-by":"publisher","first-page":"e0220262","DOI":"10.1371\/journal.pone.0220262","volume":"14","author":"N Kitanaka","year":"2019","unstructured":"Kitanaka, N. et al. Interleukin-1\u03b2 promotes interleukin-6 expression via ERK1\/2 signaling pathway in canine dermal fibroblasts. PLOS ONE 14, e0220262 (2019).","journal-title":"PLOS ONE"},{"key":"118_CR49","doi-asserted-by":"publisher","first-page":"e0222869","DOI":"10.1371\/journal.pone.0222869","volume":"14","author":"N Kitanaka","year":"2019","unstructured":"Kitanaka, N. et al. ERK1\/ATF-2 signaling axis contributes to interleukin-1\u03b2-induced MMP-3 expression in dermal fibroblasts. PLOS ONE 14, e0222869 (2019).","journal-title":"PLOS ONE"},{"key":"118_CR50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254 (1976).","journal-title":"Anal. Biochem."},{"key":"118_CR51","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388\u2013W396 (2021).","journal-title":"Nucleic Acids Res."},{"key":"118_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btac726","volume":"39","author":"J Braisted","year":"2023","unstructured":"Braisted, J. et al. RaMP-DB 2.0: a renovated knowledgebase for deriving biological and chemical insight from metabolites, proteins, and genes. Bioinformatics 39, btac726 (2023).","journal-title":"Bioinformatics"},{"key":"118_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/ar2485","volume":"10","author":"R Huber","year":"2008","unstructured":"Huber, R. et al. Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane. Arthritis Res. Ther. 10, R98 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"118_CR54","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 48, 452\u2013458 (2013).","journal-title":"Bone Marrow Transpl."}],"container-title":["npj Metabolic Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00118-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00118-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00118-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:41:26Z","timestamp":1782916886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00118-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1038\/s44324-026-00118-0","relation":{},"ISSN":["2948-2828"],"issn-type":[{"value":"2948-2828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.N. and Hiroshi S. are listed as board members of LUMIRISE Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}